These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1899 related articles for article (PubMed ID: 21508345)
21. Role and regulation of cyclooxygenase-2 during inflammation. Simon LS Am J Med; 1999 May; 106(5B):37S-42S. PubMed ID: 10390126 [TBL] [Abstract][Full Text] [Related]
22. Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium. Sales KJ; Jabbour HN Reproduction; 2003 Nov; 126(5):559-67. PubMed ID: 14611628 [TBL] [Abstract][Full Text] [Related]
23. Molecular basis for nonspecificity of nonsteroidal anti-inflammatory drugs (NSAIDs). Dwivedi AK; Gurjar V; Kumar S; Singh N Drug Discov Today; 2015 Jul; 20(7):863-73. PubMed ID: 25794602 [TBL] [Abstract][Full Text] [Related]
24. Prostaglandins and hemostasis: an overview. Stuart MJ Adv Pediatr; 1983; 30():321-64. PubMed ID: 6231843 [No Abstract] [Full Text] [Related]
25. Biosynthesis of prostaglandins. Flower RJ Ciba Found Symp; 1978 Jun 6-8; (65):123-42. PubMed ID: 113190 [TBL] [Abstract][Full Text] [Related]
26. COX-1 and COX-2 in health and disease. Adelizzi RA J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S7-12. PubMed ID: 10643175 [TBL] [Abstract][Full Text] [Related]
27. The enzymology of prostaglandin endoperoxide H synthases-1 and -2. Smith WL; Song I Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():115-28. PubMed ID: 12432913 [TBL] [Abstract][Full Text] [Related]
28. [Biological functions of cyclooxygenase 2: control of its expression and activity]. Jacquemin C J Soc Biol; 2000; 194(3-4):189-93. PubMed ID: 11324321 [TBL] [Abstract][Full Text] [Related]
29. Prostaglandins and their receptors: I. Pharmacologic receptor description, metabolism and drug use. Thierauch KH; Dinter H; Stock G J Hypertens; 1993 Dec; 11(12):1315-8. PubMed ID: 8133014 [No Abstract] [Full Text] [Related]
31. Microsomal prostaglandin E2 synthase: a safer target than cyclooxygenases? Timmers L; Pasterkamp G; de Kleijn DP Mol Interv; 2007 Aug; 7(4):195-9, 180. PubMed ID: 17827439 [TBL] [Abstract][Full Text] [Related]
32. Prostaglandins, thromboxanes, and leukotrienes in inflammation. Malmsten CL Am J Med; 1986 Apr; 80(4B):11-7. PubMed ID: 2871754 [TBL] [Abstract][Full Text] [Related]
33. Prostaglandin Pathways: Opportunities for Cancer Prevention and Therapy. Wang Q; Morris RJ; Bode AM; Zhang T Cancer Res; 2022 Mar; 82(6):949-965. PubMed ID: 34949672 [TBL] [Abstract][Full Text] [Related]
34. Potential adverse effects of cyclooxygenase-2 inhibition: evidence from animal models of inflammation. Colville-Nash PR; Gilroy DW BioDrugs; 2001; 15(1):1-9. PubMed ID: 11437671 [TBL] [Abstract][Full Text] [Related]
35. Fishing for prostanoids: deciphering the developmental functions of cyclooxygenase-derived prostaglandins. Cha YI; Solnica-Krezel L; DuBois RN Dev Biol; 2006 Jan; 289(2):263-72. PubMed ID: 16310177 [TBL] [Abstract][Full Text] [Related]
36. Biologically active derivatives of fatty acids: prostaglandins, thromboxanes, and endoperoxides. Kuehl FA; Humes JL; Beveridge GC; Van Arman CG; Egan RW Inflammation; 1977 Dec; 2(4):285-94. PubMed ID: 370001 [TBL] [Abstract][Full Text] [Related]
37. PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs. DeWitt DL; Meade EA; Smith WL Am J Med; 1993 Aug; 95(2A):40S-44S. PubMed ID: 8357002 [TBL] [Abstract][Full Text] [Related]
38. Regulation of cyclo-oxygenase-2. Stack E; DuBois RN Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):787-800. PubMed ID: 11566041 [TBL] [Abstract][Full Text] [Related]
39. Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis. Goldenberg MM Clin Ther; 1999 Sep; 21(9):1497-513; discussion 1427-8. PubMed ID: 10509845 [TBL] [Abstract][Full Text] [Related]